Echocardiographic Evaluation of the Effect of Long-Term Methylphenidate Use on Cardiovascular Functions
Authors: Tunca Çağatay , Güllü İbrahim Hakan , Demirtaş İnci Saadet , Kalkan Kamuran , Demirkol Tunca Ruken , Efe Ayşegül , Özkaya Ibiş Ayşe Nur , Taş Alperen , Taha Özkan Mehmet , Tanik Veysel Ozan , Ortaköylü Orçun , Özbeyaz Nail Burak 
Published: January 2025

Objective:

ADHD is one of the most common neurodevelopmental disorders, seen in children and adolescents, and is often treated with various pharmacological agents, especially methylphenidate. There are differing opinions in the literature regarding the cardiovascular safety of long-term methylphenidate use. Studies suggest that the drug may increase the risk of hypertension, myocardial infarction, ventricular arrhythmia, sudden cardiac death, cardiomyopathy, heart failure (HF), pulmonary hypertension, and stroke. This study aimed to compare the clinical and echocardiographic characteristics of patients diagnosed with ADHD who have been using long-acting methylphenidate for an extended period with age-gender matched healthy volunteers.

Materials and Methods:

A total of 70 patients diagnosed with ADHD, who had been using long-acting methylphenidate for 2 years or more, and 51 healthy volunteers, who were referred to our clinic, were included in our study. Patients were evaluated with basic and advanced techniques such as Motion Mode (M-mode), two-dimensional (2D), Doppler, and 2D-Speckle Tracking (STE) using transthoracic echocardiography. All other data were evaluated instantly after the processing with the strain images analysis program.

Results:

Statistically significant differences were observed between the case and control groups in terms of body mass index (BMI) and systolic blood pressure (SBP), with BMI negatively correlated and SBP positively correlated with methylphenidate use duration. There was no significant difference between the groups in apical four-chamber, three-chamber, two-chamber, and global longitudinal strain (GLS) values obtained by 2D-STE technique indicating early deterioration. The Left Ventricular (LV) lateral E′ value, which indicates diastolic dysfunction, was lower in the drug group, but still within normal limits. The lateral LV E′, Right Ventricular (RV) E′, and RV A′ values showed a significant negative correlation with the duration of drug use and remained within normal limits. Other parameters evaluating systolic/diastolic function such as E/E′, left ventricular ejection fraction (LVEF), myocardial performance index (MPI), and tricuspid/mitral annular plane systolic excursion (TAPSE/MAPSE) did not differ significantly between the groups and were within normal limits. Valve structures and regurgitations were also not significantly different between the two groups.

Conclusion:

Considering all parameters, we conclude that long-term use of long-acting methylphenidate does not cause cardiovascular dysfunction in late adolescent and early adult individuals. The observed differences in the E′ lateral value between the case and control groups, as well as the slight correlation of lateral LV E′, RV E′, and RV A′ values with the duration of use, do not directly indicate cardiac dysfunction.